{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:05:55Z","timestamp":1786478755523,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Conquer Cancer Foundation \/ American Society of Clinical Oncology Young Investigator Award","award":["K12-CA184746"],"award-info":[{"award-number":["K12-CA184746"]}]},{"name":"National Institutes of Health (NIH) K12 Paul Calabresi Career Development Award for Clinical Oncology"},{"name":"MSKCC Clinical Research Methodology Curriculum (CRMC)\/ Weill Cornell Clinical & Translational Science Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.leukres.2020.106453","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:10:23Z","timestamp":1600207823000},"page":"106453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6357-6475","authenticated-orcid":false,"given":"K.","family":"Menghrajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Famulare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2020.106453_bib0005","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1073\/pnas.88.23.10735","article-title":"Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias","volume":"88","author":"Ziemin-van der Poel","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.leukres.2020.106453_bib0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","article-title":"New nomenclature for chromatin-modifying enzymes","volume":"131","author":"Allis","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2020.106453_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106453_bib0020","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2020.106453_bib0025","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/leu.2012.319","article-title":"Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation","volume":"27","author":"Chen","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106453_bib0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.leu.2402135","article-title":"An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners","volume":"15","author":"Huret","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106453_bib0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.leukres.2020.106453_bib0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.seminoncol.2008.04.012","article-title":"Therapy-related myeloid leukemia","volume":"35","author":"Godley","year":"2008","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.leukres.2020.106453_bib0045","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0050","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0060","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0065","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children\u2019s Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0075","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/leu.2015.345","article-title":"Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)","volume":"30","author":"Bhatnagar","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106453_bib0080","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1038\/leu.2015.143","article-title":"Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23\/MLL rearrangement (MLL-r AML)","volume":"29","author":"Pigneux","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2020.106453_bib0085","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0090","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.2008.16.7981","article-title":"Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data\u2013based meta-analysis of the German acute myeloid leukemia intergroup","volume":"27","author":"Krauter","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2020.106453_bib0095","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","article-title":"AML with 11q23\/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases","volume":"102","author":"Schoch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2011.08869.x","article-title":"Primary refractory acute myeloid leukaemia - in search of better definitions and therapies","volume":"155","author":"Ravandi","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2020.106453_bib0105","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2020.106453_bib0110","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1002\/cncr.25263","article-title":"Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group","volume":"116","author":"Rowe","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2020.106453_bib0115","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1182\/blood-2010-12-328302","article-title":"Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23\/MLL-rearranged AML patients: results of an international study","volume":"117","author":"Coenen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1182\/blood.V100.1.29","article-title":"Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study","volume":"100","author":"Wolman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2020.106453_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1200\/JCO.2011.41.5505","article-title":"Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON\/SAKK Cooperative Group","volume":"31","author":"Gr\u00f6schel","year":"2013","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620301582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:42Z","timestamp":1758934842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620301582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":25,"alternative-id":["S0145212620301582"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106453","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106453"}}